Skip to search.
 TSX Up 0.28% TSX Ventures Up 0.23%

Titan Pharmaceuticals, Inc. (TTNP)

-NasdaqCM
4.40 Dec 5, 4:00PM EST
|Pre-Market : 4.40 0.00 (0.00%) 4:49PM EST - Nasdaq Real Time Price
Prev Close:4.40
Open:N/A
Bid:4.20 x 400
Ask:4.40 x 100
1y Target Est:10.00
Beta:1.27331
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:2.57 - 8.74
Volume:0
Avg Vol (3m):134,488
Market Cap:93.28M
P/E (ttm):17.53
EPS (ttm):0.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
TTNP 0.00%93.28M
LLY70.98B
PFE191.70B
JNJ304.54B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.21
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :0.23
Quarterly EPS Est (Dec-16) :-0.12
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Titan Pharmaceuticals, Inc., a specialty pharmaceutical company, develops proprietary therapeutics for the treatment of serious medical disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback